ClinicalTrialsFinder
RecruitingPhase 1NCT07450911

The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

Sponsor

ReValve Solutions Inc.

Enrollment

20 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Mitral Regurgitation

Summary

An evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ReValve System for people with mitral regurgitation. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEReValve System

Mitral Valve Replacement Device

Locations(3)

Healthycore

Tbilisi, Georgia

Tbilisi Heart and Vascular Center

Tbilisi, Georgia

Tiblisi Heart Center

Tbilisi, Georgia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07450911

Related Trials

ATLAS (AltaValve) Pivotal Trial

NCT0646574529 locations

Capstan Medical TMVR Study: FIH

NCT066001913 locations

Cephea Early Feasibility Study

NCT0506100422 locations

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT0549699837 locations

The CardioClip Study

NCT062414301 location